Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 984027, 10 pages
http://dx.doi.org/10.1093/ecam/nep020
Original Article

Inhibition of Anchorage-Independent Proliferation and G0/G1 Cell-Cycle Regulation in Human Colorectal Carcinoma Cells by 4,7-Dimethoxy-5-Methyl-l,3-Benzodioxole Isolated from the Fruiting Body of Antrodia camphorate

1Department of Chemistry, Tunghai University, Taichung, Taiwan
2Graduate Institute of Biomedical Technology, Taipei Medical University, Taipei 110, Taiwan
3Department of Environmental and Occupational Health, National Cheng Kung University Medical College, Tainan, Taiwan
4Graduate Institute of Neuroscience, Taipei Medical University, Taipei, Taiwan
5Department of Applied Chemistry, Chung Shan Medical University, Taichung 402, Taiwan

Received 15 December 2008; Accepted 16 February 2009

Copyright © 2011 Hsiu-Man Lien et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y.-C. Hseu, H.-L. Yang, Y.-C. Lai, J.-G. Lin, G.-W. Chen, and Y.-H. Chang, “Induction of apoptosis by Antrodia camphorata in human premyelocytic leukemia HL-60 cells,” Nutrition and Cancer, vol. 48, no. 2, pp. 189–197, 2004. View at Google Scholar
  2. C.-Y. Chang, Z.-N. Huang, H.-H. Yu et al., “The adjuvant effects of Antrodia Camphorata extracts combined with anti-tumor agents on multidrug resistant human hepatoma cells,” Journal of Ethnopharmacology, vol. 118, no. 3, pp. 387–395, 2008. View at Publisher · View at Google Scholar · View at PubMed
  3. A. Figueredo, M. E. Coombes, and S. Mukherjee, “Adjuvant therapy for completely resected stage II colon cancer,” Cochrane Database of Systematic Reviews, vol. 16, Article ID CD005390, 2008. View at Google Scholar
  4. T. Kuwai, T. Nakamura, T. Sasaki et al., “Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy,” Clinical and Experimental Metastasis, vol. 25, no. 4, pp. 477–489, 2008. View at Publisher · View at Google Scholar · View at PubMed
  5. R. Durai, S. Y. Yang, A. M. Seifalian, and M. C. Winslet, “Principles and applications of gene therapy in colon cancer,” Journal of Gastrointestinal and Liver Diseases, vol. 17, no. 1, pp. 59–67, 2008. View at Google Scholar
  6. T. R. Asmis and L. Saltz, “Systemic therapy for colon cancer,” Gastroenterology Clinics of North America, vol. 37, no. 1, pp. 287–295, 2008. View at Publisher · View at Google Scholar · View at PubMed
  7. C. Kurkjian, A. J. Murgo, and S. Kummar, “Treatment of recurrent metastatic colon cancer in the age of modern adjuvant therapy,” Clinical Colorectal Cancer, vol. 7, no. 5, pp. 321–324, 2008. View at Publisher · View at Google Scholar · View at PubMed
  8. D. Niewolik, B. Vojtesek, and J. Kovarik, “p53 derived from human tumour cell lines and containing distinct point mutations can be activated to bind its consensus target sequence,” Oncogene, vol. 10, pp. 881–890, 1995. View at Google Scholar
  9. Y.-S. Ho, Y.-J. Wang, and J.-K. Lin, “Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells,” Molecular Carcinogenesis, vol. 16, no. 1, pp. 20–31, 1996. View at Google Scholar
  10. L. Hui, Y. Zheng, Y. Yan, J. Bargonetti, and D. A. Foster, “Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D,” Oncogene, vol. 25, no. 55, pp. 7305–7310, 2006. View at Publisher · View at Google Scholar · View at PubMed
  11. B. Bressac, K. M. Galvin, T. J. Liang, K. J. Isselbacher, J. R. Wands, and M. Ozturk, “Abnormal structure and expression of p53 gene in human hepatocellular carcinoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 5, pp. 1973–1977, 1990. View at Google Scholar
  12. B. B. Knowles, C. C. Howe, and D. P. Aden, “Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen,” Science, vol. 209, pp. 497–499, 1980. View at Google Scholar
  13. Y. Imai, K. Ohnishi, J. Yasumoto, A. Kajiwara, N. Yamakawa, A. Takahashi et al., “Glycerol enhances radiosensitivity in a human oral squamous cell carcinoma cell line (Ca9-22) bearing a mutant p53 gene via Bax-mediated induction of apoptosis,” Oral Oncology, vol. 41, pp. 631–636, 2005. View at Google Scholar
  14. K. M. Siddiqui and D. P. Chopra, “Primary and long term epithelial cell cultures from human fetal normal colonic mucosa,” In Vitro, vol. 20, no. 11, pp. 859–868, 1984. View at Google Scholar
  15. R.-J. Chen, W.-S. Lee, Y.-C. Liang et al., “Ketoconazole induces G0/G1 arrest in human colorectal and hepatocellular carcinoma cell lines,” Toxicology and Applied Pharmacology, vol. 169, no. 2, pp. 132–141, 2000. View at Publisher · View at Google Scholar · View at PubMed
  16. W.-S. Lee, M. K. Jain, B. M. Arkonac et al., “Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines,” Circulation Research, vol. 82, no. 8, pp. 845–851, 1998. View at Google Scholar
  17. Y.-S. Ho, Y.-J. Wang, and J.-K. Lin, “Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells,” Molecular Carcinogenesis, vol. 16, no. 1, pp. 20–31, 1996. View at Google Scholar
  18. W.-S. Lee, R.-J. Chen, Y.-J. Wang et al., “In vitro and in vivo studies of the anticancer action of terbinafine in human cancer cell lines: G0/G1 p53-associated cell cycle arrest,” International Journal of Cancer, vol. 106, no. 1, pp. 125–137, 2003. View at Publisher · View at Google Scholar · View at PubMed
  19. Y.-S. Ho, C.-H. Wu, H.-M. Chou et al., “Molecular mechanisms of econazole-induced toxicity on human colon cancer cells: G0/G1 cell cycle arrest and caspase 8-independent apoptotic signaling pathways,” Food and Chemical Toxicology, vol. 43, no. 10, pp. 1483–1495, 2005. View at Publisher · View at Google Scholar · View at PubMed
  20. O. H. Krämer, S. K. Knauer, D. Zimmermann, R. H. Stauber, and T. Heinzel, “Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis,” Oncogene, vol. 27, no. 6, pp. 732–740, 2008. View at Publisher · View at Google Scholar · View at PubMed
  21. K. Takagi, Y. Sowa, O. M. Cevik, R. Nakanishi, and T. Sakai, “CDK inhibitor enhances the sensitivity to 5-fluorouracil in colorectal cancer cells,” International Journal of Oncology, vol. 32, no. 5, pp. 1105–1110, 2008. View at Google Scholar
  22. C.-H. Wu, J.-H. Jeng, Y.-J. Wang et al., “Antitumor effects of miconazole on human colon carcinoma xenografts in nude mice through induction of apoptosis and G0/G1 cell cycle arrest,” Toxicology and Applied Pharmacology, vol. 180, no. 1, pp. 22–35, 2002. View at Publisher · View at Google Scholar · View at PubMed
  23. L. J. Ko and C. Prives, “p53: puzzle and paradigm,” Genes and Development, vol. 10, no. 9, pp. 1054–1072, 1996. View at Google Scholar
  24. A. J. Levine, “p53, the cellular gatekeeper for growth and division,” Cell, vol. 88, no. 3, pp. 323–331, 1997. View at Publisher · View at Google Scholar
  25. M. Takahashi, M. Furihata, N. Akimitsu et al., “A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1,” Clinical & Experimental Metastasis, vol. 25, pp. 517–529, 2008. View at Google Scholar
  26. J. Mei, H. Hu, M. McEntee, H. Plummer III, P. Song, and H.-C. R. Wang, “Transformation of non-cancerous human breast epithelial cell line MCF10A by the tobacco-specific carcinogen NNK,” Breast Cancer Research and Treatment, vol. 79, no. 1, pp. 95–105, 2003. View at Publisher · View at Google Scholar
  27. Y.-C. Hseu, S.-C. Chen, P.-C. Tsai et al., “Inhibition of cyclooxygenase-2 and induction of apoptosis in estrogen-nonresponsive breast cancer cells by Antrodia camphorata,” Food and Chemical Toxicology, vol. 45, no. 7, pp. 1107–1115, 2007. View at Publisher · View at Google Scholar · View at PubMed
  28. H.-L. Yang, C.-S. Chen, W.-H. Chang et al., “Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata,” Cancer Letters, vol. 231, no. 2, pp. 215–227, 2006. View at Publisher · View at Google Scholar · View at PubMed
  29. C.-M. Ho, C.-C. Huang, C.-J. Huang et al., “Effects of antrodia camphorata on viability, apoptosis, and [Ca2+]i in PC3 human prostate cancer cells,” Chinese Journal of Physiology, vol. 51, no. 2, pp. 78–84, 2008. View at Google Scholar
  30. T. Y. Song, S. L. Hsu, C. T. Yeh, and G. C. Yen, “Mycelia from Antrodia camphorata in Submerged culture induce apoptosis of human hepatoma HepG2 cells possibly through regulation of Fas pathway,” Journal of Agricultural and Food Chemistry, vol. 53, pp. 5559–5564, 2005. View at Google Scholar
  31. C.-C. Peng, K.-C. Chen, R. Y. Peng, C.-H. Su, and H. M. Hsieh-Li, “Human urinary bladder cancer T24 cells are susceptible to the Antrodia camphorata extracts,” Cancer Letters, vol. 243, no. 1, pp. 109–119, 2006. View at Publisher · View at Google Scholar · View at PubMed
  32. J.-J. Chen, W.-J. Lin, C.-H. Liao, and P.-C. Shieh, “Anti-inflammatory benzenoids from Antrodia camphorata,” Journal of Natural Products, vol. 70, no. 6, pp. 989–992, 2007. View at Publisher · View at Google Scholar · View at PubMed
  33. C. H. Chiang, W. De-Peng, I. W. Cherng, and U. C. Chuen-Her, “A sesquiterpene lactone, phenyl and biphenyl compounds from Antrodia cinnamomea,” Phytochemistry, vol. 39, no. 3, pp. 613–616, 1995. View at Publisher · View at Google Scholar
  34. S. Rowan, R. L. Ludwig, Y. Haupt, S. Bates, X. Lu, M. Oren et al., “Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant,” EMBO Journal, vol. 15, pp. 827–838, 1996. View at Google Scholar
  35. W. Yan, G. Liu, A. Scoumanne, and X. Chen, “Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations,” Cancer Research, vol. 68, no. 16, pp. 6789–6796, 2008. View at Publisher · View at Google Scholar · View at PubMed
  36. A. Gradilone, F. M. Pulcinelli, L. V. Lotti et al., “Celecoxib upregulates multidrug resistance proteins in colon cancer: lack of synergy with standard chemotherapy,” Current Cancer Drug Targets, vol. 8, no. 5, pp. 414–420, 2008. View at Publisher · View at Google Scholar
  37. M. W. Frazier, X. He, J. Wang, Z. Gu, J. L. Cleveland, and G. P. Zambetti, “Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain,” Molecular and Cellular Biology, vol. 18, no. 7, pp. 3735–3743, 1998. View at Google Scholar
  38. R. E. Harris, J. Beebe-Donk, and G. A. Alshafie, “Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors,” BMC Cancer, vol. 8, article 237, 2008. View at Publisher · View at Google Scholar · View at PubMed
  39. T. Yamauchi, M. Watanabe, H. Hasegawa et al., “The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer,” Anticancer Research, vol. 23, no. 1, pp. 245–249, 2003. View at Google Scholar